These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 20530323)

  • 41. Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.
    De Stefano N; Giorgio A; Battaglini M; De Leucio A; Hicking C; Dangond F; Giovannoni G; Sormani MP
    Mult Scler; 2018 Feb; 24(2):222-226. PubMed ID: 28140753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS.
    Zivadinov R; Medin J; Khan N; Korn JR; Bergsland N; Dwyer MG; Chitnis T; Naismith RT; Alvarez E; Kinkel P; Cohan S; Hunter SF; Silva D; Weinstock-Guttman B;
    J Neuroimaging; 2018 Jul; 28(4):399-405. PubMed ID: 29749661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The spatio-temporal relationship between concurrent lesion and brain atrophy changes in early multiple sclerosis: A post-hoc analysis of the REFLEXION study.
    Gentile G; Mattiesing RM; Brouwer I; van Schijndel RA; Uitdehaag BMJ; Twisk JWR; Kappos L; Freedman MS; Comi G; Jack D; Barkhof F; De Stefano N; Vrenken H; Battaglini M
    Neuroimage Clin; 2023; 38():103397. PubMed ID: 37086648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progressive multiple sclerosis: characteristics and management.
    Hawker K
    Neurol Clin; 2011 May; 29(2):423-34. PubMed ID: 21439451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm.
    Cole JH; Raffel J; Friede T; Eshaghi A; Brownlee WJ; Chard D; De Stefano N; Enzinger C; Pirpamer L; Filippi M; Gasperini C; Rocca MA; Rovira A; Ruggieri S; Sastre-Garriga J; Stromillo ML; Uitdehaag BMJ; Vrenken H; Barkhof F; Nicholas R; Ciccarelli O;
    Ann Neurol; 2020 Jul; 88(1):93-105. PubMed ID: 32285956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishing pathological cut-offs for lateral ventricular volume expansion rates.
    Dwyer MG; Hagemeier J; Bergsland N; Horakova D; Korn JR; Khan N; Uher T; Medin J; Silva D; Vaneckova M; Havrdova EK; Zivadinov R
    Neuroimage Clin; 2018; 18():494-501. PubMed ID: 29527505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis.
    van den Elskamp IJ; Boden B; Dattola V; Knol DL; Filippi M; Kappos L; Fazekas F; Wagner K; Pohl C; Sandbrink R; Polman CH; Uitdehaag BM; Barkhof F
    Neuroradiology; 2010 Oct; 52(10):875-81. PubMed ID: 20049424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
    Branger P; Parienti JJ; Sormani MP; Defer G
    PLoS One; 2016; 11(3):e0149685. PubMed ID: 26983008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis--a prospective, non-randomized pilot study.
    Portaccio E; Stromillo ML; Goretti B; Hakiki B; Giorgio A; Rossi F; De Leucio A; De Stefano N; Amato MP
    Eur J Neurol; 2013 Jun; 20(6):986-90. PubMed ID: 23057658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes.
    Jakimovski D; Zivadinov R; Bergsland N; Ramasamy DP; Hagemeier J; Genovese AV; Hojnacki D; Weinstock-Guttman B; Dwyer MG
    Neuroimage Clin; 2021; 29():102554. PubMed ID: 33472143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease.
    Azevedo CJ; Cen SY; Khadka S; Liu S; Kornak J; Shi Y; Zheng L; Hauser SL; Pelletier D
    Ann Neurol; 2018 Feb; 83(2):223-234. PubMed ID: 29328531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early recognition and diagnosis of multiple sclerosis.
    Waubant E
    J Clin Psychiatry; 2012 Apr; 73(4):e14. PubMed ID: 22579157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups.
    Tubridy N; Ader HJ; Barkhof F; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):50-5. PubMed ID: 9436727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain volume loss in individuals over time: Source of variance and limits of detectability.
    Narayanan S; Nakamura K; Fonov VS; Maranzano J; Caramanos Z; Giacomini PS; Collins DL; Arnold DL
    Neuroimage; 2020 Jul; 214():116737. PubMed ID: 32171923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The measurement and clinical relevance of brain atrophy in multiple sclerosis.
    Bermel RA; Bakshi R
    Lancet Neurol; 2006 Feb; 5(2):158-70. PubMed ID: 16426992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain volume and fatigue in patients with postpoliomyelitis syndrome.
    Trojan DA; Narayanan S; Francis SJ; Caramanos Z; Robinson A; Cardoso M; Arnold DL
    PM R; 2014 Mar; 6(3):215-20. PubMed ID: 24060387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A longitudinal MRI study of cervical cord atrophy in multiple sclerosis.
    Valsasina P; Rocca MA; Horsfield MA; Copetti M; Filippi M
    J Neurol; 2015 Jul; 262(7):1622-8. PubMed ID: 25929665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation and atrophy in multiple sclerosis: MRI associations with disease course.
    Lin X; Blumhardt LD
    J Neurol Sci; 2001 Aug; 189(1-2):99-104. PubMed ID: 11535239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis.
    Richert ND; Howard T; Frank JA; Stone R; Ostuni J; Ohayon J; Bash C; McFarland HF
    Neurology; 2006 Feb; 66(4):551-6. PubMed ID: 16505310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The natural history of brain volume loss among patients with multiple sclerosis: a systematic literature review and meta-analysis.
    Vollmer T; Signorovitch J; Huynh L; Galebach P; Kelley C; DiBernardo A; Sasane R
    J Neurol Sci; 2015 Oct; 357(1-2):8-18. PubMed ID: 26238166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.